California Cancer Reporting System Standards, Volume III

 

Eureka Edits

IF413 CS SSF 2, Extension, Ovary Schema (CS)

 

Edit Sets

Eureka Hospital Transmit

Eureka Tumor Level

Eureka Admission Level

 

Fields

Behavior Code ICD-O-3  [NAACCR# 523]

CS Extension [NAACCR #2810]

CS Site-Specific Factor 2  [NAACCR #2890]

CS Site-Specific Factor 25  [NAACCR #2879]

Histologic Type ICD-O-3  [NAACCR #522]

Primary Site  [NAACCR #400]

 

Message

If CS Extension = 000, CS Site Specific Factor 2 must = 987.

 

Specification

This edit verifies that if CS Extension indicates a non-invasive lesion, then CS Site-Specific Factor 2 (FIGO Stage) is coded consistently for the Ovary schema.

 

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

 

This edit is skipped if any of the following conditions are true:

  1. CS Site-Specific Factor 2 is blank or = 988

  2. CS Extension is blank

  3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  4. CS schema is invalid

If CS schema is Ovary:

If CS Extension = 000 (In situ, intraepithelial, noninvasive, preinvasive),

then CS Site-Specific 2 must = 987 [Carcinoma in situ (intraepithelial, noninvasive, preinvasive)]

 

Historical Changes

In the SEER*Edits software, the title of this edit is: IF367

7/27/11 This new edit was created to comply with NAACCR 12.1.A.
04/2014 Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll."